| gap-2026-lancet-deme | Implementation gaps in the 2024 Lancet dementia prevention recommendations for u | open | 0.70 | 0.68 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-prion-prote | Prion protein species barrier mechanisms and their relevance to sporadic neurode | resolved | 0.68 | 0.66 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-sex-differe | Sex-specific adrenergic receptor mechanisms driving sex differences in Alzheimer | resolved | 0.63 | 0.66 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-neu1-ppca-a | Neu1 and PPCA lysosomal complex regulation of APP metabolism and amyloidogenesis | open | 0.70 | 0.68 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-s100a9-nlrp | Retinal microglia S100A9-mediated NLRP3 inflammasome activation as a systemic in | resolved | 0.62 | 0.64 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-dark-microg | Ultrastructural and molecular drivers of dark microglia formation in neurodegene | open | 0.67 | 0.66 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-microbiome- | Mechanistic pathways by which microbiome-based interventions influence neurodege | resolved | 0.65 | 0.68 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-ferroptosis | Iron-dependent protein aggregation cross-talk in Alzheimer's and Parkinson's dis | resolved | 0.72 | 0.68 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-peripheral- | Peripheral-to-brain transport routes and tissue distribution of pathological neu | open | 0.68 | 0.65 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-abeta-a2v-v | Structural basis for A2V protective versus A2T pathogenic effects on amyloid-bet | open | 0.70 | 0.69 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-il8-neuroto | IL-8 receptor network and downstream signaling mediating neurotoxicity in Alzhei | resolved | 0.63 | 0.68 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-lrrk2-g2019 | LRRK2 G2019S regulation of clusterin and impaired astrocyte uptake of alpha-synu | resolved | 0.65 | 0.67 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-peripheral- | Mechanisms of peripheral alpha-synuclein preformed fibril transcytosis across th | resolved | 0.72 | 0.68 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-trem2-aep-a | TREM2-dependent microglial processing of alpha-synuclein fibrils via AEP truncat | resolved | 0.68 | 0.69 | 2026-04-28 | 0 | | neurodegeneration |
| gap-2026-dark-microg | Mechanistic chain from microglial ISR activation to toxic lipid secretion and sy | open | 0.70 | 0.69 | 2026-04-28 | 0 | | neurodegeneration |
| gap-20260427-221856 | What is the evidence for neuronal identity transcription factors as therapeutic | investigating | 0.90 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| cgi-e4443e5acea5 | Unresolved cancer mechanism: Si xian formula (SXF) alleviates carboplatin-induce | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-16db8e844bb7 | Unresolved cancer mechanism: Sexual dimorphism and acute stress modulation of in | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-c7f5d4059dcb | Unresolved cancer mechanism: Thrombospondin-1 triggers calreticulin expression i | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-feb3c858102d | Unresolved cancer mechanism: NFYC upregulates KLF1 expression and activate LDHA | open | 0.60 | 0.00 | 2026-04-27 | 0 | | glioblastoma |
| cgi-49bb58434121 | Unresolved cancer mechanism: A neurotensin receptor type 1-derived pepducin acts | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-4e8b21a00bc7 | Unresolved cancer mechanism: FABP4 Couples Lipid Metabolism to PD-L1 Stabilizati | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-825e00782510 | Unresolved cancer mechanism: A microbiota-derived bile acid overcomes antibiotic | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-2c649a09fe23 | Unresolved cancer mechanism: Metabolic maintenance of breast cancer cells and me | open | 0.60 | 0.00 | 2026-04-27 | 0 | | breast-cancer |
| cgi-14feadfb5af2 | Unresolved cancer mechanism: Cell fusion reprograms tumor cells and promotes RUN | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-bdfbc524531b | Unresolved cancer mechanism: Sphingosine-1-Phosphate Receptor 3 Confers Tumor Me | open | 0.60 | 0.00 | 2026-04-27 | 0 | | lung-cancer |
| cgi-329b401229ea | Unresolved cancer mechanism: RTA‑408 induces p38‑dependent apoptosis and suppres | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-19b818b7e8a8 | Unresolved cancer mechanism: Vitexicarpin Directly Targets RSK2 to Attenuate Mig | open | 0.60 | 0.00 | 2026-04-27 | 0 | | breast-cancer |
| cgi-3cea00f6b48c | Unresolved cancer mechanism: Microphthalmia/Transcription Factor E (MiT/TFE) Pat | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-45bb77405774 | Unresolved cancer mechanism: Single-Cell Transcriptomics Reveals Immune Modulati | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-780795b99a6c | Unresolved cancer mechanism: Sorghum Promotes Cell Proliferation Through Activat | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-5b0b4190420d | Unresolved cancer mechanism: High-Sugar Consumption Induces Anxiety-Like Behavio | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-9cb03e84a7cd | Unresolved cancer mechanism: TRIM24 Regulates Adaptation to Glucose Deprivation | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-a93d6c146194 | Unresolved cancer mechanism: Orally Administered Rhamnan Sulfate from Monostroma | open | 0.60 | 0.00 | 2026-04-27 | 0 | | lung-cancer |
| cgi-47aaab3dbc2f | Unresolved cancer mechanism: Integrative Multi-Omics Analysis Reveals HNRNPLL as | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| cgi-f5879cae7122 | Unresolved cancer mechanism: Reprogramming of the m(6)A Epitranscriptome Drives | open | 0.60 | 0.00 | 2026-04-27 | 0 | | oncology-literature |
| gap-methodol-2026042 | Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua | resolved | 0.92 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| gap-methodol-2026042 | Methodology challenge: dataset 'SEA-AD Differential Expression: AD vs Control (M | resolved | 0.92 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| gap-methodol-2026042 | Methodology challenge: dataset 'Allen Brain SEA-AD MTG 10x snRNA-seq' — evaluate | resolved | 0.92 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| gap-methodol-2026042 | Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat | resolved | 0.92 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| gap-methodol-2026042 | Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia | resolved | 0.92 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| gap-methodol-2026042 | Methodology challenge: notebook 'Blood-brain barrier transport mechanisms for an | resolved | 0.92 | 0.00 | 2026-04-27 | 0 | | neurodegeneration |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Computational Lineage Reconstruction and Unc | open | 0.81 | 0.81 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Recording Neuroimmune and Degeneration-linke | open | 0.83 | 0.83 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Spatial Lineage Atlases and Cross-platform H | open | 0.83 | 0.83 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Clinical Translation, Ethics, and Biosafety | open | 0.83 | 0.83 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Molecular Recording and Cellular Memory Syst | open | 0.82 | 0.82 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Perturb-seq Coupled to Lineage and Exposure | open | 0.79 | 0.79 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Delivery Systems for Longitudinal In-vivo Ce | open | 0.82 | 0.82 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |
| gap-synthetic-biolog | Gap in Seattle Hub lineage tracing: Mammalian Synthetic Gene Circuits and Logic | open | 0.81 | 0.81 | 2026-04-26 | 0 | | synthetic-biology-lineage-tracing |